MYR 0.07
(-6.67%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 15.91 Million MYR | -69.23% |
2022 | 51.72 Million MYR | 186.95% |
2021 | 18.02 Million MYR | 28.31% |
2020 | 14.04 Million MYR | 167.45% |
2019 | 5.25 Million MYR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 Q1 | 29.44 Million MYR | -40.5% |
2023 Q4 | 15.91 Million MYR | 8.09% |
2023 Q3 | 14.72 Million MYR | 5.13% |
2023 Q2 | 14 Million MYR | -52.43% |
2022 Q1 | 26.89 Million MYR | 0.0% |
2022 Q4 | 49.49 Million MYR | 23.31% |
2022 Q2 | 33.95 Million MYR | 26.26% |
2022 Q3 | 40.14 Million MYR | 18.21% |
2021 FY | 18.02 Million MYR | 28.31% |
2020 FY | 14.04 Million MYR | 167.45% |
2019 FY | 5.25 Million MYR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
QES Group Berhad | 97.42 Million MYR | 83.661% |
Optimax Holdings Berhad | 51.78 Million MYR | 69.26% |
Pharmaniaga Berhad | 2.18 Billion MYR | 99.273% |
Apex Healthcare Berhad | 204.34 Million MYR | 92.21% |